Aspartame Litigation

Aspartame, used as a sweetner in "diet" products, can have multiple neurotoxic, metabolic, allergenic, fetal and carcinogenic effects. Commonly known as NutraSweet® and Equal®, Aspartame is now used by over two-thirds of the population.

The FDA approved Aspartame as a low-nutritive sweetener in 1981. It is a synthetic chemical consisting of two amino acids, phenylalanine (50 percent) and aspartic acid (40 percent), and a methyl ester (10 percent) that promptly becomes free methyl alcohol (methanol; wood alcohol). The latter is a severe poison.

Some of the reactions to Aspartame include the initiation or aggravation of diabetes mellitus, hypoglycemia, convulsions, headache, depression, hyperthyroidism, hypertension and arthritis; the simulation of multiple sclerosis, Alzheimer's disease and lupus erythematosus; aspartame addiction; and it is linked to brain tumors.

When Aspartame use has been stopped, the prompt improvement of symptoms (grand mal seizures, headache, itching, rashes, severe gastrointestinal reactions) and their recurrence within minutes or hours after resuming Aspartame, provides direct evidence of its adverse effect on humans.

Six pilots who had lost their licenses for unexplained seizures while consuming Aspartame products, sought to have their licenses reinstated by demonstrating the affects Aspartame had on them.